Sickle-cell Anemia Therapeutics Market 2019 in US: Drivers, Trends & Growth Analysis

1
Sickle-cell Anemia Therapeutics Market in the US
2015-2019
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published January 2014
• Single User PDF US 2500
• Corporate User PDF US 3500

2
Sickle-cell Anemia Therapeutics Market in the US
2015-2019

• Sickle-cell anemia is a disease characterized by
  the presence of sickle-shaped erythrocytes. While
  normal erythrocytes have a life span of 120 days,
  sickle-shaped erythrocytes die within 10 to 20
  days. The bone marrow is unable to compensate for
  the excessive loss of erythrocytes, thereby
  leading to anemia. It is an inheritable disorder
  passed on across generations. The prevalence of
  the sickle-cell gene varies between different
  ethnic groups and geographical locations.
• Analysts forecast the Sickle-cell Anemia
  Therapeutics market in the US to grow at a CAGR
  of 17.10 percent over the period 2014-2019.
• Covered in this Report
• This report covers the present scenario and the
  growth prospects of the Sickle-cell Anemia
  Therapeutics market in the US for the period
  2015-2019. To calculate the market size, the
  report considers the revenue generated through
  the sales of the US FDA-approved drugs used for
  the treatment of sickle-cell anemia.
• Sickle-cell Anemia Therapeutics Market in US
  2015-2019, has been prepared based on an in-depth
  market analysis with inputs from industry
  experts. It covers the Sickle-cell Anemia
  Therapeutics market landscape in the US and its
  growth prospects in the coming years. The report
  also includes a discussion of the key vendors
  operating in this market.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Sickle-cell Anemia Therapeutics Market in the US
2015-2019

• Single User License US 2500 Inquire for
  Discount _at_ http//www.reportsnreports.com/contacts
  /Discount.aspx?name323205.
• Key Vendors
• Bristol-Myers Squibb, Future Prominent Vendors,
  Baxter, Bluebird Bio, Daiichi Sankyo, Eli Lilly,
  Emmaus Medical, GlycoMimetics, HemaQuest
  Pharmaceuticals, Mast Therapeutics, Merck Sharp
  Dohme, Pfizer, Selexys Pharmaceuticals
• Market Driver
• Unmet Medical Needs
• Market Challenge
• Side Effects Associated with Current Therapies
• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name323205.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Sickle-cell Anemia Therapeutics Market in the US
2015-2019

• Market Trend
• Increased Focus on Adult Patients
• Key Questions Answered in this Report
• What will the market size be in 2019 and what
  will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats
  faced by the key vendors?
• What are the strengths and weaknesses of the key
  vendors?
• Table of Contents
• 01. Executive Summary
• 02. List of Abbreviations
• 03. Scope of the Report

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Sickle-cell Anemia Therapeutics Market in the US
2015-2019

• 04. Market Research Methodology
• 05. Disease Overview
• 06. Introduction
• 07. Market Landscape
• 08. Buying Criteria
• 09. Market Growth Drivers
• 10. Drivers and their Impact
• 11. Market Challenges
• 12. Impact of Drivers and Challenges
• 13. Market Trends
• 14. Trends and their Impact
• 15. Vendor Landscape
• 16. Future Prominent Vendors
• 17. Key Vendor Analysis
• 18. Other Reports in this Series
• Inquiry Before Buying _at_ http//www.reportsnreports
  .com/contacts/Discount.aspx?name323205.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Sickle-cell Anemia Therapeutics Market in the US
2015-2019

• List of Exhibits
• Exhibit 1 Product Offering for Sickle-cell
  Anemia Therapeutics Market in USExhibit 2
  Market Research MethodologyExhibit 3 Normal
  erythrocytes and Sickle-shaped ErythrocytesExhibi
  t 4 Impact of Sickled Erythrocytes on Blood
  FlowExhibit 5 Structure of HemoglobinExhibit
  6 Genetic Basis of Sickle-cell AnemiaExhibit 7
  Global Distribution of Sickle-cell GeneExhibit
  8 Symptoms of Sickle-cell DiseaseExhibit 9
  Inheritance Pattern of Sickle-cell Anemia 
• Exhibit 10 Blood Sample of Sickle-cell Disease
  Patients Before and After Stem Cell
  TransplantationExhibit 11 Laboratory Tests
  Recommended Before Initiation of Hydroxyurea
  TherapyExhibit 12 Facts for Hemoglobin
  DisordersExhibit 13 RuSH Project SitesExhibit
  14 PHRESH Primary FocusExhibit 15 Sickle-cell
  Anemia Therapeutics Market in US 2014-2019 (US
  million)Exhibit 16 Life Expectancy of
  Sickle-cell Disease Patients in USExhibit 17
  Sickle-cell Disease Treatment Demonstration
  Program Regional Collaborative Technical
  Assistance Aims of Funding

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
7
Sickle-cell Anemia Therapeutics Market in the US
2015-2019

• Exhibit 18 Bristol-Myers Squibb Co. Key Product
  Offerings (Based on Therapeutic Areas)Exhibit
  19 Bristol-Myers Squibb Co. Revenue by
  Geographical Segmentation 2013
• Explore Report on Pharmaceuticals Market.
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Sickle-cell
  Anemia Therapeutics Market in the US 2015-2019
  report OR for any other market research and
  intelligence needs you may have for your business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.